Come up with a name for your new list and we'll add to it:
MabCure raised a round of funding on January 20, 2011. Investors include
Roswell Capital Partners.
MabCure is a U.S. biotechnology company whose mission is to change the perception of cancer as being a largely incurable disease. MabCure owns proprietary technology for the creation of unique and hig…